Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GLI2 |
| Upstream (Parents) |
|---|
| (<<) NR1I3 → GLI2 |
| (<<) SALL1 → GLI2 |
| (<<) GATA4 → GLI2 |
| (<<) HHEX → GLI2 |
| (<<) PPARG → GLI2 |
| (<<) MLXIPL → GLI2 |
| (<<) NEUROG1 → GLI2 |
| (<<) EPAS1 → GLI2 |
| (<<) HMGB2 → GLI2 |
| (<<) KLF11 → GLI2 |
| Downstream (Children) |
|---|
| GLI2 → FOXD1 (>>) |
| GLI2 → HOXA1 (>>) |
| GLI2 → ISL1 (>>) |
| GLI2 → MXD1 (>>) |
| GLI2 → ZSCAN12 (>>) |
| GLI2 → TBX2 (>>) |
| GLI2 → RUNX1 (>>) |
| GLI2 → POU4F3 (>>) |
| GLI2 → TBX5 (>>) |
| GLI2 → FUBP1 (>>) |
| GLI2 → NFATC4 (>>) |
| GLI2 → HOXB3 (>>) |
| GLI2 → HCFC1 (>>) |
| GLI2 → KLF4 (>>) |
| GLI2 → C11orf9 (>>) |
| GLI2 → MYCL1 (>>) |
| GLI2 → CTBP1 (>>) |
| GLI2 → MYOD1 (>>) |
